Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.

ABSTRACT: Gaining full benefits from osteoporosis medications requires long-term treatment. Investigating the real-world persistence of women receiving osteoporosis medications in the UK, we found that most patients stop treatment within a year. To prevent osteoporotic fragility fractures, long-term treatment persistence must be improved.

Introduction

Persistence with osteoporosis therapies has historically been poor. To treat this chronic and progressive disease, it is essential that patients receive the full benefit of these medications. We estimated persistence and compliance with osteoporosis therapies in a large sample of postmenopausal women in the UK.

Methods

Data were obtained from the Clinical Practice Research Datalink for all women aged 50 years and over or women with early

SUBMITTER: Morley J 

PROVIDER: S-EPMC7076063 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature